TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26986056

Group type: EXPERIMENTAL
Intervention: History of child trauma and poor mental health (PTSD, depressive symptoms, alcohol abuse)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: History of child trauma
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: PTSD symptomatology
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Highly equitable gender attitudes
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Child trauma, other trauma, PTSD
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Child trauma
Number of subjects: 416
Study: 24765899

Group type: COMPARATOR
Intervention: Intrathecal morphine (ITM) 0 mg (control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (ITM) 0.3 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (ITM) 0.1 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (ITM) 0.2 mg
Number of subjects: 60
Study: 23539257

Group type: EXPERIMENTAL
Intervention: Prucalopride 2 mg once daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Oral contraceptive (ethinylestradiol 0.035 mg + norethisterone 1 mg)
Number of subjects: 16
Study: 20630168

Group type: EXPERIMENTAL
Intervention: Multivitamin/mineral supplementation (MVM)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 18528407

Group type: EXPERIMENTAL
Intervention: Newly developed device for measuring carotid-femoral PWV
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard device (Complior) for measuring carotid-femoral PWV
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Brachial-ankle PWV
Number of subjects: 21
Study: 16931264

Group type: EXPERIMENTAL
Intervention: 5 mL injection volume of peribulbar anesthesia
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2 mL injection volume of peribulbar anesthesia
Number of subjects: 20
Study: 12601528

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10973836

Group type: EXPERIMENTAL
Intervention: Eptifibatide infusion for up to 72 to 96 hours
Number of subjects: 4035

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4035
Study: 8793039

Group type: EXPERIMENTAL
Intervention: Competence training
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Memory training
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Psychomotor training
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Combined psychomotor and memory training
Number of subjects: 309

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 309
Study: 1467860

Group type: EXPERIMENTAL
Intervention: Irrigation (mean of 15 litres of irrigating fluid used)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No irrigation
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Irrigation
Number of subjects: 200
Study: 6421249

Group type: EXPERIMENTAL
Intervention: SF‐SP (spansule)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Gastro‐soluble tegafur (control)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 126
Study: 30872737

Group type: EXPERIMENTAL
Intervention: Tongxinluo (TXL)
Number of subjects: 1212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1212
Study: 29600482

Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.25% with 1:400 000 epinephrine)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (0.4 mL·kg‐1 of 0.9% saline)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Comparison of both groups
Number of subjects: 6
Study: 26658804

Group type: EXPERIMENTAL
Intervention: Lactulose oral solution and polyethylene glycol electrolyte powder
Number of subjects: 90

Group type: COMPARATOR
Intervention: Polyethylene glycol electrolyte powder only
Number of subjects: 90
Study: 24577471

Group type: EXPERIMENTAL
Intervention: 200 mg caffeine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 22471290

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg twice daily
Number of subjects: 173

Group type: COMPARATOR
Intervention: Aspirin 100 mg once daily
Number of subjects: 173

Group type: COMPARATOR
Intervention: Aspirin 200 mg once daily
Number of subjects: 173
Study: 20499122

Group type: EXPERIMENTAL
Intervention: Ultrasound and standard physical therapy (group III)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham ultrasound in addition to standard physical therapy (group II)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard physical therapy including hot pack and exercise program (group I)
Number of subjects: 45
Study: 17110604

Group type: EXPERIMENTAL
Intervention: GW501516 10 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: GW501516 2.5 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 16120074

Group type: EXPERIMENTAL
Intervention: Ziprasidone 40 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 11975715

Group type: EXPERIMENTAL
Intervention: 13Leu‐motilin
Number of subjects: 8

Group type: COMPARATOR
Intervention: 0.9% NaCl (saline)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: motilin + ondansetron
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: motilin
Number of subjects: 8
Study: 10419240

Group type: EXPERIMENTAL
Intervention: Cornstarch (0.3 g/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 7593726

Group type: EXPERIMENTAL
Intervention: Moclobemide (400 mg daily)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Clomipramine (150 mg daily)
Number of subjects: 147
Study: 2292549

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin/azlocillin
Number of subjects: 108

Group type: COMPARATOR
Intervention: Gentamicin/azlocillin
Number of subjects: 108
Study: 7205167

Group type: EXPERIMENTAL
Intervention: Cephalexin administered twice a day
Number of subjects: 154

Group type: COMPARATOR
Intervention: Cephalexin administered four times a day
Number of subjects: 154
Study: 30734465

Group type: EXPERIMENTAL
Intervention: Circulating RNAs (miRNAs)
Number of subjects: 57
Study: 30094983

Group type: EXPERIMENTAL
Intervention: Herbal cake-partitioned moxibustion combined with Rhinocort nasal spray (2 jets/day for each nostril, 64 µg/jet) for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rhinocort nasal spray (2 jets/day for each nostril, 64 µg/jet) for 8 weeks
Number of subjects: 60
Study: 27322311

Group type: EXPERIMENTAL
Intervention: Omegaven(®) 10% 100 mL/day for five days postoperatively
Number of subjects: 119

Group type: COMPARATOR
Intervention: Regular nutrition
Number of subjects: 119
Study: 24072724

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation for 12 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 18
Study: 21542114

Group type: EXPERIMENTAL
Intervention: IV normal saline (NS) ± N-acetylcysteine (NAC) (n = 161)
Number of subjects: 320

Group type: COMPARATOR
Intervention: IV sodium bicarbonate (NaHCO(3)) ± NAC (n = 159)
Number of subjects: 320
Study: 19358990

Group type: EXPERIMENTAL
Intervention: Propofol 0.25 mg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Propofol 0.5 mg/kg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 17767511

Group type: EXPERIMENTAL
Intervention: parecoxib 40 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: ASA 1000 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 14
Study: 16582548

Group type: EXPERIMENTAL
Intervention: MORA bioresonance therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 12013159

Group type: EXPERIMENTAL
Intervention: Relaxation and counselling intervention performed by a senior doctor
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 9678615

Group type: COMPARATOR
Intervention: Group A - letter signed by the GP, with a prefixed appointment
Number of subjects: 16454

Group type: EXPERIMENTAL
Intervention: Group B - open-ended invitation, signed by the GP
Number of subjects: 16454

Group type: EXPERIMENTAL
Intervention: Group C - letter signed by the program coordinator, with a prefixed appointment
Number of subjects: 16454

Group type: EXPERIMENTAL
Intervention: Group D - extended letter signed by the GP, with a prefixed appointment
Number of subjects: 16454
Study: 8583221

Group type: EXPERIMENTAL
Intervention: Familial cases of Parkinson's disease
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Age at onset in familial cases
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Age at onset within a generation
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Genetic transmission
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Incomplete penetrance
Number of subjects: 31
Study: 2696648

Group type: EXPERIMENTAL
Intervention: Local Anaesthesia (LA)
Number of subjects: 111

Group type: COMPARATOR
Intervention: General Anaesthesia (GA)
Number of subjects: 111
Study: 57244

Group type: EXPERIMENTAL
Intervention: Thiacetazone 150 mg with Isoniazid 300 mg once daily
Number of subjects: 72

Group type: COMPARATOR
Intervention: Paraaminosalicyclic acid 12 gm with Isoniazid 300 mg daily in divided doses
Number of subjects: 72
Study: 30782715

Group type: EXPERIMENTAL
Intervention: Moderate intensity training programme (3 sessions of 45 minutes per week for 2 years)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Low intensity training programme (3 sessions of 45 minutes per week for 2 years)
Number of subjects: 110
Study: 27789238

Group type: EXPERIMENTAL
Intervention: Social support from significant others, family members, and friends
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Resilience (measured using the Connor‐Davidson Resilience Scale)
Number of subjects: 163
Study: 26306000

Group type: EXPERIMENTAL
Intervention: DBS plus optimal drug therapy (DBS + ODT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Optimal drug therapy (ODT)
Number of subjects: 0
Study: 23207188

Group type: EXPERIMENTAL
Intervention: Prolonged chewing (30 seconds per mouthful)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Habitual chewing
Number of subjects: 43

Group type: COMPARATOR
Intervention: Habitual chewing with pauses
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Prolonged chewing
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 43
Study: 20828790

Group type: EXPERIMENTAL
Intervention: naproxcinod 750 mg bid
Number of subjects: 1020

Group type: EXPERIMENTAL
Intervention: naproxcinod 375 mg bid
Number of subjects: 1020

Group type: COMPARATOR
Intervention: naproxen 500 mg bid
Number of subjects: 1020

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1020
Study: 18708688

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (CR: 0.25 g/kg lean-tissue mass for 7 days; 0.06 g/kg lean-tissue mass for 49 days; n=22, 12 males, 10 females)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Isocaloric placebo (PL; n=20, 12 males, 8 females)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Resistance-exercise training (RET)
Number of subjects: 42
Study: 16582524

Group type: EXPERIMENTAL
Intervention: Midazolam intramuscularly (Group M)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Midazolam intranasally (Group N)
Number of subjects: 40
Study: 14514369

Group type: EXPERIMENTAL
Intervention: Standard large trauma craniotomy (SLTC)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Routine craniotomy (RC)
Number of subjects: 230
Study: 11427833

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia and sedation with propofol/alfentanil (Group I)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Continuous infusion with propofol/alfentanil (Group II)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Nurse-administered midazolam/meperidine (Group III)
Number of subjects: 150
Study: 9566014

Group type: EXPERIMENTAL
Intervention: Electronic dental anesthesia (EDA)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Local anesthetic injection (LA)
Number of subjects: 32
Study: 8067483

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clinical management
Number of subjects: 40
Study: 3142349

Group type: EXPERIMENTAL
Intervention: Erythromycin estolate (500 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Erythromycin ethylsuccinate (600 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both erythromycin esters
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Erythromycin estolate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Erythromycin ethylsuccinate
Number of subjects: 12
Study: 4156289

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 20

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 20
Study: 28291587

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (D4)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (D5)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Dexmedetomidine (D2)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Acepromazine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (D3, D4, D5)
Number of subjects: 6
Study: 25279807

Group type: EXPERIMENTAL
Intervention: QAM dosing of extended-release hydromorphone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: QPM dosing of extended-release hydromorphone
Number of subjects: 15
Study: 23102797

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol 800 mcg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Buccal misoprostol 800 mcg
Number of subjects: 90
Study: 21903473

Group type: EXPERIMENTAL
Intervention: Sequential chemotherapy (bolus and infusional fluorouracil plus leucovorin, followed by oxaliplatin and irinotecan)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Combination chemotherapy (FOLFOX6 followed by FOLFIRI)
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Sequential chemotherapy
Number of subjects: 410
Study: 18691696

Group type: EXPERIMENTAL
Intervention: Computer prototype
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Reduced fidelity prototypes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: More attractive mobile phone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Less appealing mobile phone
Number of subjects: 60
Study: 16352689

Group type: EXPERIMENTAL
Intervention: rosiglitazone (RSG; 8 mg/d; n = 13)
Number of subjects: 26
Study: 15484307

Group type: EXPERIMENTAL
Intervention: Conscious sedation with i.v. midazolam (Mi-group, 52 pts)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Throat anaesthesia only (Co-group, 62 pts)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Presence of a relative during the procedure (Re-group, 58 pts)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Additional information with a videotape (Vi-group, 54 pts)
Number of subjects: 226
Study: 11737035

Group type: EXPERIMENTAL
Intervention: Wheezing children in Sweden
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Wheezing children in Estonia
Number of subjects: 275

Group type: COMPARATOR
Intervention: Domestic crowding
Number of subjects: 275

Group type: COMPARATOR
Intervention: Mean baseline FEV1
Number of subjects: 275
Study: 9433630

Group type: EXPERIMENTAL
Intervention: Model‐heterogeneity test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Admixture test
Number of subjects: 0
Study: 31283521

Group type: EXPERIMENTAL
Intervention: Aspirin desensitization combined with long-term Aspirin therapy
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 29425912

Group type: EXPERIMENTAL
Intervention: Low-dose prophylaxis antibiotics
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Antibiotics for urinary tract infection treatment
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Intermittent self-catheterisation
Number of subjects: 26
Study: 27168265

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week (following 80 mg at week 0)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Adalimumab (hfPGA 0/1 achieved)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (hfPGA 0/1 not achieved)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Adalimumab (with psoriatic arthritis history)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (without psoriatic arthritis history)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Adalimumab (BMI <30.28 kg/m2)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (BMI ≥30.28 kg/m2)
Number of subjects: 72
Study: 24993605

Group type: EXPERIMENTAL
Intervention: Eplerenone plus standard care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 0
Study: 21565436

Group type: EXPERIMENTAL
Intervention: High-fidelity human simulators (HFS)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standardized patients (SP)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Community volunteers (CV)
Number of subjects: 44
Study: 19855325

Group type: EXPERIMENTAL
Intervention: Conventional curvilinear movement arcs
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Multidirectional exercises
Number of subjects: 14
Study: 16960776

Group type: EXPERIMENTAL
Intervention: pegylated IFN-alpha 2a and ribavirin
Number of subjects: 265
Study: 15229059

Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg/day)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Reboxetine (8 mg/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 11554887

Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation with reduced off time to < or = 1.1 min
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard on/off cycle of 30 s on and 5 min off
Number of subjects: 154
Study: 9592991

Group type: EXPERIMENTAL
Intervention: Activated protein C resistance (APCR)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Factor V Leiden
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Phenotype APCR
Number of subjects: 65
Study: 7512433

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 20 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 125 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 8
Study: 3139179

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg twice daily
Number of subjects: 135

Group type: COMPARATOR
Intervention: Wedge mastectomy plus excision of symptomatic axillary lymph nodes
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 135

Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 135
Study: 30566211

Group type: EXPERIMENTAL
Intervention: Home-based tele-rehabilitation (TR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard cardiac rehabilitation (CR)
Number of subjects: 0
Study: 27126710

Group type: EXPERIMENTAL
Intervention: fiber, fish oil and carotenoid-enriched tube feed formula
Number of subjects: 51
Study: 25195590

Group type: EXPERIMENTAL
Intervention: Every 2 weeks cetuximab (500 mg/m²)
Number of subjects: 311

Group type: COMPARATOR
Intervention: Weekly cetuximab (250 mg/m²)
Number of subjects: 311
Study: 23281805

Group type: EXPERIMENTAL
Intervention: Paclitaxel (200 mg/m2, day 1) plus carboplatin (AUC 6 mg/mL/min, day 1) every 3 weeks (Arm A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gemcitabine (1000 mg/m2, days 1 and 8) plus carboplatin (AUC 5 mg/mL/min, day 1) every 3 weeks (Arm B)
Number of subjects: 50
Study: 21668751

Group type: EXPERIMENTAL
Intervention: IV ketamine infusion (2 µg/kg/min)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: IV ketamine infusion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 30
Study: 18267006

Group type: EXPERIMENTAL
Intervention: Interferon gamma (1 x 106 IU recombinant human IFN gamma intramuscularly, daily for one month and then three times per week up to 6 months)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Interferon gamma
Number of subjects: 32
Study: 17087052

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA)-rich fish oil-fortified drink (0.60 g EPA + 0.26 g docosahexaenoic acid/d) for 12 weeks
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 151
Study: 15531765

Group type: EXPERIMENTAL
Intervention: Disease Management (DM) program
Number of subjects: 1069
Study: 11892888

Group type: EXPERIMENTAL
Intervention: 6 mg of melatonin
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 9412917

Group type: EXPERIMENTAL
Intervention: Relaxation music
Number of subjects: 59

Group type: COMPARATOR
Intervention: No music (control)
Number of subjects: 59
Study: 8030430

Group type: EXPERIMENTAL
Intervention: Fluvoxamine for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 0
Study: 2446877

Group type: EXPERIMENTAL
Intervention: iloprost
Number of subjects: 24

Group type: COMPARATOR
Intervention: hydroxy-ethyl starch (HES)
Number of subjects: 24
Study: 31452471

Group type: EXPERIMENTAL
Intervention: PROPER intervention - structured and biannually repeated multidisciplinary medication review
Number of subjects: 0
Study: 31740863

Group type: EXPERIMENTAL
Intervention: Spinal Mobilisation with Arm Movement along with neurodynamics and manual traction
Number of subjects: 31

Group type: COMPARATOR
Intervention: Neurodynamics and manual traction
Number of subjects: 31
Study: 28329785

Group type: EXPERIMENTAL
Intervention: Exercise + Beet Root Juice (BRJ)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Exercise + Placebo
Number of subjects: 26
Study: 25864872

Group type: EXPERIMENTAL
Intervention: 2% Lidocaine with 1:100,000 epinephrine using the ICPAT
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% sterile saline using the ICPAT
Number of subjects: 40
Study: 23167603

Group type: EXPERIMENTAL
Intervention: Rifampicin (RIF)
Number of subjects: 171
Study: 21801494

Group type: EXPERIMENTAL
Intervention: 0.80 FiO(2)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.30 FiO(2)
Number of subjects: 24
Study: 19335686

Group type: EXPERIMENTAL
Intervention: Topical tacrolimus
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Topical betamethasone
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Zinc pyrithione shampoo
Number of subjects: 3
Study: 16684385

Group type: EXPERIMENTAL
Intervention: Daily supplements for 5 days a week
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Weekly supplements
Number of subjects: 415

Group type: COMPARATOR
Intervention: No supplements (control group)
Number of subjects: 415